216 results
Page 3 of 11
8-K
EX-99.2
90dz2hf ver
12 Nov 21
TherapeuticsMD Announces Leadership Changes; Appointment of Industry Veteran, Hugh O’Dowd, as Chief Executive Officer
6:47am
SC TO-I
EX-99
rozbsfxnpcc0in
26 Aug 21
Issuer tender offer statement
4:55pm
8-K
EX-99.1
fk95wz7 rjlxir
9 Aug 21
TherapeuticsMD Announces Appointment of Hugh O’Dowd as President
4:35pm
8-K
EX-99.2
n2v0yw3gz3u7y
4 Aug 21
TherapeuticsMD Announces Second Quarter 2021 Financial Results
7:00am
8-K
EX-99.2
uha7yc7my4
6 May 21
TherapeuticsMD Announces First Quarter 2021 Financial Results
7:00am
8-K
EX-99.1
3epvjbf gd
6 May 21
TherapeuticsMD Announces First Quarter 2021 Financial Results
7:00am
S-3ASR
zvrdpc7x7e1 rxu0
4 Mar 21
Automatic shelf registration
12:00am
8-K
EX-99.2
xcvbvb6vc1h3n5
2 Mar 21
TherapeuticsMD Announces Fourth Quarter and Full-Year 2020 Financial Results
7:00am
424B2
wb6xix6n8s
16 Feb 21
Prospectus for primary offering
6:17am
424B5
sxg4g2b
10 Feb 21
Prospectus supplement for primary offering
5:11pm
8-K
EX-99.1
hi7lkk tekouf5kl87f
13 Jan 21
Entry into a Material Definitive Agreement
8:50am
424B5
57pnjyfl
27 Nov 20
Prospectus supplement for primary offering
4:46pm
424B2
mbprjn kr7zddl4mbj2
12 Nov 20
Prospectus for primary offering
5:18pm
424B5
i24pukw tyfj0ui5g077
9 Nov 20
Prospectus supplement for primary offering
5:27pm